Cardiopulmonary exercise test: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
No edit summary |
|||
Line 5: | Line 5: | ||
== Long COVID == | == Long COVID == | ||
In a single CPET test, Post-COVID-19 patients exhibited markedly reduced peak exercise aerobic capacity (VO2) compared to controls and impaired oxygen extraction, even in those without cardiopulmonary disease.<ref>{{Cite journal|last=Singh|first=Inderjit|last2=Joseph|first2=Phillip|last3=Heerdt|first3=Paul M.|last4=Cullinan|first4=Marjorie|last5=Lutchmansingh|first5=Denyse D.|last6=Gulati|first6=Mridu|last7=Possick|first7=Jennifer D.|last8=Systrom|first8=David M.|last9=Waxman|first9=Aaron B.|date=2021-08-10|title=Persistent Exertional Intolerance after COVID-19: Insights from Invasive Cardiopulmonary Exercise Testing.|url=https://journal.chestnet.org/article/S0012-3692(21)03635-7/abstract|journal=CHEST|language=English|volume=0|issue=0|doi=10.1016/j.chest.2021.08.010|issn=0012-3692}}</ref> | In a single CPET test, [[Long COVID|Post-COVID-19]] patients exhibited markedly reduced peak exercise aerobic capacity (VO2) compared to controls and impaired oxygen extraction, even in those without cardiopulmonary disease.<ref>{{Cite journal|last=Singh|first=Inderjit|last2=Joseph|first2=Phillip|last3=Heerdt|first3=Paul M.|last4=Cullinan|first4=Marjorie|last5=Lutchmansingh|first5=Denyse D.|last6=Gulati|first6=Mridu|last7=Possick|first7=Jennifer D.|last8=Systrom|first8=David M.|last9=Waxman|first9=Aaron B.|date=2021-08-10|title=Persistent Exertional Intolerance after COVID-19: Insights from Invasive Cardiopulmonary Exercise Testing.|url=https://journal.chestnet.org/article/S0012-3692(21)03635-7/abstract|journal=CHEST|language=English|volume=0|issue=0|doi=10.1016/j.chest.2021.08.010|issn=0012-3692}}</ref> | ||
== See also == | == See also == | ||
Line 11: | Line 11: | ||
== References == | == References == | ||
<references /> |
Revision as of 18:04, August 11, 2021
Cardiopulmonary exercise testing (CPET or CPEX), also referred to as a VO2 (oxygen consumption) test, is a specialized type of stress test or exercise test that measures your exercise ability. It has been used extensively to study Myalgic encephalomyelitis/Chronic fatigue syndrome and is considered a potential biomarker for the syndrome.
ME/CFS[edit | edit source]
Long COVID[edit | edit source]
In a single CPET test, Post-COVID-19 patients exhibited markedly reduced peak exercise aerobic capacity (VO2) compared to controls and impaired oxygen extraction, even in those without cardiopulmonary disease.[1]
See also[edit | edit source]
References[edit | edit source]
- ↑ Singh, Inderjit; Joseph, Phillip; Heerdt, Paul M.; Cullinan, Marjorie; Lutchmansingh, Denyse D.; Gulati, Mridu; Possick, Jennifer D.; Systrom, David M.; Waxman, Aaron B. (August 10, 2021). "Persistent Exertional Intolerance after COVID-19: Insights from Invasive Cardiopulmonary Exercise Testing". CHEST. 0 (0). doi:10.1016/j.chest.2021.08.010. ISSN 0012-3692.